Zheng Xing Xing Ye Ri Bao·2025-09-24 08:40Market Overview - On September 24, the biopharmaceutical sector rose by 0.09% compared to the previous trading day, with Ganli Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3853.64, up 0.83%, while the Shenzhen Component Index closed at 13356.14, up 1.8% [1] Individual Stock Performance - Ganli Pharmaceutical (603087) closed at 79.34, with a significant increase of 10.00% and a trading volume of 343,300 shares, resulting in a transaction value of 2.696 billion yuan [1] - Other notable performers included: - Sanofi (688336) at 55.98, up 5.11% with a transaction value of 431 million yuan [1] - Aidi Pharmaceutical (688488) at 15.26, up 4.88% with a transaction value of 174 million yuan [1] - Nuoviz (688105) at 22.65, up 4.47% with a transaction value of 91.03 million yuan [1] Capital Flow Analysis - The biopharmaceutical sector saw a net inflow of 86.36 million yuan from institutional investors, while retail investors experienced a net outflow of 69.34 million yuan [2] - The capital flow for individual stocks showed that Ganli Pharmaceutical had a net inflow of 14.4 million yuan from institutional investors, but a net outflow of 85.14 million yuan from retail investors [3] - Changchun High-tech (000661) had a net inflow of 43.56 million yuan from institutional investors, while retail investors faced a net outflow of 88.37 million yuan [3]